Sign In
Buy MED
$10.62
-0.400 (-3.63%)
At Close: Jun 23, 2026
Medifast's Q1 Earnings on The Horizon: Key Insights for Investors
01:20pm, Friday, 01'st May 2026
MED reports Q1 fiscal 2026 May 4; revenue seen down 36.3% and EPS at a 55-cent loss as coach base and demand stay pressured.
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Medifast, Inc. (NYSE: MED)
09:00am, Tuesday, 14'th Apr 2026
NEW YORK, April 14, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Medifast, Inc. (NYSE: MED) on behalf of the company's shareholders. The investigation seeks to det
Medifast's New Product Pipeline: Key Catalyst for Comeback?
10:56am, Tuesday, 07'th Apr 2026
MED's science-led metabolic health push and new product pipeline could spark a turnaround as it targets GLP-1 transition users and profitability growth.
Medifast (NYSE:MED) CEO Acquires $178,724.58 in Stock
04:29am, Saturday, 28'th Mar 2026
Medifast Inc (NYSE: MED - Get Free Report) CEO Daniel Chard acquired 17,678 shares of the stock in a transaction on Friday, March 20th. The stock was bought at an average price of $10.11 per share, wi
Medifast Announces Cooperation Agreement with Steamboat Capital
08:30am, Friday, 20'th Mar 2026
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today announced the company's Board of Di
Medifast (MED) Down 5.7% Since Last Earnings Report: Can It Rebound?
12:36pm, Thursday, 19'th Mar 2026
Medifast (MED) reported earnings 30 days ago. What's next for the stock?
Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
08:30am, Friday, 20'th Feb 2026
BALTIMORE--(BUSINESS WIRE)--As part of its continued focus on improving metabolic health, Medifast® (NYSE: MED) today announced that OPTAVIA's comprehensive metabolic health system is available for r
Medifast Q4 Earnings Call Highlights
04:07am, Thursday, 19'th Feb 2026
Medifast (NYSE: MED) reported fourth-quarter and full-year 2025 results while outlining continued efforts to reposition the business around metabolic health, highlighting early signs of improving coac
Medifast Q4 Loss Wider Than Expected, Revenues Decline 37% Y/Y
11:21am, Wednesday, 18'th Feb 2026
MED posts a wider quarterly loss as revenue tumbles 36.9% on a sharp drop in OPTAVIA coaches, despite beating revenue estimates.
Medifast (MED) Reports Q4 Loss, Beats Revenue Estimates
06:30pm, Tuesday, 17'th Feb 2026
Medifast (MED) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to earnings of $0.1 per share a year ago.
Medifast, Inc. (MED) Q4 2025 Earnings Call Transcript
06:24pm, Tuesday, 17'th Feb 2026
Medifast, Inc. (MED) Q4 2025 Earnings Call Transcript
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
04:05pm, Tuesday, 17'th Feb 2026
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the fourth quarter and full ye
Medifast's Q4 Earnings on Deck: What Could Shape MED's Results?
10:10am, Friday, 13'th Feb 2026
MED is likely to post a sharp Q4 revenue drop and a wider loss as active earning coaches decline and GLP-1 pressure weighs despite retention and pricing efforts.
Analysts Estimate Medifast (MED) to Report a Decline in Earnings: What to Look Out for
11:01am, Tuesday, 10'th Feb 2026
Medifast (MED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medifast (MED) to Release Earnings on Tuesday
04:46am, Tuesday, 10'th Feb 2026
Medifast (NYSE: MED - Get Free Report) will likely be issuing its Q4 2025 results after the market closes on Tuesday, February 17th. Analysts expect Medifast to post earnings of ($0.80) per share and
